44 related articles for article (PubMed ID: 20818716)
21. Soluble CD40 and its ligand CD154 in patients with Graves' ophthalmopathy during combined therapy with corticosteroids and teleradiotherapy.
Myśliwiec J; Waligórski D; Nikołajuk A; Górska M
Adv Med Sci; 2007; 52():104-8. PubMed ID: 18217399
[TBL] [Abstract][Full Text] [Related]
22. The effect of methylprednisolone pulse treatment on cytokine network in Graves ophthalmopathy.
Lacka K; Manuszewska E; Korczowska I; Lacki JK
Curr Eye Res; 2007 Mar; 32(3):291-7. PubMed ID: 17453949
[TBL] [Abstract][Full Text] [Related]
23. Radioiodine therapy and Graves' ophthalmopathy.
Sisson JC; Schipper MJ; Nelson CC; Freitas JE; Frueh BR
J Nucl Med; 2008 Jun; 49(6):923-30. PubMed ID: 18483104
[TBL] [Abstract][Full Text] [Related]
24. Therapeutic outcomes of mycophenolate mofetil and glucocorticoid in thyroid-associated ophthalmopathy patients.
Li LF; Xue JL; Guan L; Su FF; Wang H; Zhang DF
Front Endocrinol (Lausanne); 2023; 14():1140196. PubMed ID: 37025403
[TBL] [Abstract][Full Text] [Related]
25. [Evaluation of methylprednisolone pulse therapy versus combined therapy with prednisolone and cyclosporine in the treatment of infiltrative ophthalmopathy in Graves' disease].
Dalmatova АВ; Grineva EN
Probl Endokrinol (Mosk); 2007 Oct; 53(5):27-30. PubMed ID: 31627654
[TBL] [Abstract][Full Text] [Related]
26. Short and long-term effects of high-dose intravenous methylprednisolone pulse therapy on thyroid-associated ophthalmopathy.
Liu X; Wang S; Qin L; Qiang W; Dahal M; Fan P; Gao S; Shi B
Exp Ther Med; 2016 Aug; 12(2):901-908. PubMed ID: 27446294
[TBL] [Abstract][Full Text] [Related]
27. Plasma exchange therapy for severe Graves' ophthalmopathy.
Glinoer D; Schrooyen M
Horm Res; 1987; 26(1-4):184-9. PubMed ID: 3596467
[TBL] [Abstract][Full Text] [Related]
28. Comparative Efficacy of Medical Treatments for Thyroid Eye Disease: A Network Meta-Analysis.
Xu N; Cui Y; Xie T; Zheng M
J Ophthalmol; 2018; 2018():7184163. PubMed ID: 30647961
[TBL] [Abstract][Full Text] [Related]
29. Thyroid eye disease: towards an evidence base for treatment in the 21st century.
Gillespie EF; Smith TJ; Douglas RS
Curr Neurol Neurosci Rep; 2012 Jun; 12(3):318-24. PubMed ID: 22354545
[TBL] [Abstract][Full Text] [Related]
30. Surgical or medical decompression as a first-line treatment of optic neuropathy in Graves' ophthalmopathy? A randomized controlled trial.
Wakelkamp IM; Baldeschi L; Saeed P; Mourits MP; Prummel MF; Wiersinga WM
Clin Endocrinol (Oxf); 2005 Sep; 63(3):323-8. PubMed ID: 16117821
[TBL] [Abstract][Full Text] [Related]
31. Plasma filtration in the treatment of Graves' ophthalmopathy: A randomized study.
Cap J; Ceeova V; Skacha M; Rezek P; Vlcek P; Blaha M
J Clin Apher; 2010; 25(4):209-15. PubMed ID: 20818716
[TBL] [Abstract][Full Text] [Related]
32. [Treatment of Grave's ophthalmopathy with high doses of corticosteroids].
Cirić J; Zarković M; Stojanović M; Pepenezić Z; Randjelović G; Gligorović M; Trbojević B; Drezgić M; Nesović M
Srp Arh Celok Lek; 2000; 128(5-6):179-83. PubMed ID: 11089418
[TBL] [Abstract][Full Text] [Related]
33. Clinical results of anti-inflammatory therapy in Graves' ophthalmopathy and association with thyroidal autoantibodies.
Eckstein AK; Plicht M; Lax H; Hirche H; Quadbeck B; Mann K; Steuhl KP; Esser J; Morgenthaler NG
Clin Endocrinol (Oxf); 2004 Nov; 61(5):612-8. PubMed ID: 15521965
[TBL] [Abstract][Full Text] [Related]
34. A pilot study to monitor Graves' ophthalmopathy with a combination of pattern-reversal and motion-onset visual evoked potentials.
Szanyi J; Kremlacek J; Kubova Z; Langrova J; Kuba M
J Clin Apher; 2012; 27(6):295-301. PubMed ID: 22811284
[TBL] [Abstract][Full Text] [Related]
35. Management of Graves' ophthalmopathy.
Wiersinga WM
Nat Clin Pract Endocrinol Metab; 2007 May; 3(5):396-404. PubMed ID: 17452966
[TBL] [Abstract][Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
